Intersect ENT

Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. The company was founded in 2003 by Don Eaton and is headquartered in Menlo Park, California, United States.

Intersect ENT headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical sector. The company focuses on Health Care and has secured $17.2B in funding across 72 round(s). With a team of 251-500 employees, Intersect ENT is actively contributing to advancements in Health Care. Their latest funding round, Series C - Intersect ENT, raised $31.0M. Discover more about their projects, partnerships, and impact on our platform.